Upon targeting efflux transporters, reprogramming cancer metabolism, inducing mitochondrial apoptosis, and synergizing with chemotherapeutic agents, berberine exhibits the multi-faceted nature of drug resistance
4.3 Study limitations This study provides a valuable reference for clinical practice, yet it is essential to recognize its inherent limitations
Despite current standard treatment involving maximal surgical resection followed by radiotherapy and temozolomide (TMZ)-based chemotherapy, the median survival time remains less than 15 months for most patients [3,4,5,6]
Ingredients: Water, Niacinamide, Helianthus Annuus (Sunflower) Seed Oil, Glutathione, Cetearyl Olivate, Polyacrylamide, Sorbitan Olivate, 1,2-Hexanediol, C13-14 Isoparaffin, Pulsatilla Koreana Extract, Usnea Barbata (Lichen) Extract, Zanthoxylum Piperitum Fruit Extract, Carbomer, Sodium Hyaluronate, Triethanolamine, Fragrance, Glycerin, Laureth-7, Butylene Glycol, Limonene, Hexyl Cinnamal, Linalool, Ethylhexylglycerin, Achillea Millefolium Extract, Malva Sylvestris (Mallow) Extract, Melissa Officinalis Leaf Extract, Mentha Piperita (Peppermint) Leaf Extract, Primula Veris Extract, Veronica Officinalis Extract, Hydrogenated Lecithin, Geraniol, Hamamelis Virginiana (Witch Hazel) Leaf Extract, Morus Alba Bark Extract, Phyllanthus emblica Fruit Extract, Trichosanthes kirilowii root Extract, Polyglyceryl-10 stearate, Benzyl Benzoate, Panthenol, Sodium Ascorbyl Phosphate, Tocopheryl Acetate, Glyceryl Arachidonate, Glyceryl Linolenate, Acetyl Hexapeptide-8, Biotin, Folic Acid, Pyridoxine, Retinyl Palmitate, Thiamine HCL, Copper Tripeptide-1, Oligopeptide-29, Cyanocobalamin, Oligopeptide-32, Palmitoyl Pentapeptide-4
